Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/13/1998 | CA2279929A1 Phenylbenzimidazole derivatives as ligands for gaba receptors |
08/13/1998 | CA2279927A1 Fibrinogen receptor antagonist prodrugs |
08/13/1998 | CA2279863A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases |
08/13/1998 | CA2279834A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
08/13/1998 | CA2279636A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
08/13/1998 | CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
08/13/1998 | CA2279233A1 Arginine silicate complex and use thereof |
08/13/1998 | CA2278854A1 Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes |
08/13/1998 | CA2277022A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation |
08/13/1998 | CA2273895A1 Bicyclic inhibitors of protein farnesyl transferase |
08/13/1998 | CA2253221A1 Bi-aromatic compounds, compositions containing them and uses |
08/13/1998 | CA2251999A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell |
08/12/1998 | EP0857725A1 (N-(pyridinylmethyl)-heterocyclic)-ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
08/12/1998 | EP0857724A1 Sulfonamide substituted compounds, process for their preparation, their use as medicine or for diagnostic purpose |
08/12/1998 | EP0857718A1 Endothelin antagonist |
08/12/1998 | EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient |
08/12/1998 | EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption |
08/12/1998 | EP0857484A1 Pge 1?-containing freeze-dried preparation and process for the production thereof |
08/12/1998 | EP0857483A1 Substituted aminopyridines in the treatment of glucose metabolism disorders |
08/12/1998 | EP0857481A1 Use of an organopolysiloxane for the fixing and/or the prolonged release of perfume |
08/12/1998 | EP0857428A2 Dietetic soy based products and method for production thereof |
08/12/1998 | EP0857214A1 Novel saliva binding protein |
08/12/1998 | EP0857213A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening miroorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
08/12/1998 | EP0857208A2 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
08/12/1998 | EP0857207A1 Microporous pathogen-killing composition |
08/12/1998 | EP0857175A1 Novel human cysteine protease |
08/12/1998 | EP0857174A1 Urokinase plasminogen activator fragments |
08/12/1998 | EP0857173A1 Meiosis regulating compounds |
08/12/1998 | EP0857172A1 Phosphorus containing cythesine derivatives |
08/12/1998 | EP0857171A2 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
08/12/1998 | EP0857071A1 (radio) labelled biotin derivatives |
08/12/1998 | EP0857069A1 Methods of preserving microorganisms |
08/12/1998 | EP0857068A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
08/12/1998 | EP0857067A1 Radioprotectors |
08/12/1998 | EP0857066A1 Use of nitroflavonoids for the treatment of anxiety |
08/12/1998 | EP0857065A2 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
08/12/1998 | EP0857064A1 Stabilised pharmaceutical preparations containing thyroid hormone |
08/12/1998 | EP0857063A1 Compositions and methods for buccal delivery of pharmaceutical agents |
08/12/1998 | EP0857062A2 Method of producing multi-layer medicaments in solid form for oral or rectal administration |
08/12/1998 | EP0857061A1 Solubilisation methods |
08/12/1998 | EP0857056A1 Antiperspirant or deodorant composition with silicone latex |
08/12/1998 | EP0857047A1 Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
08/12/1998 | EP0857020A1 Wet granulation formulation of a growth hormone secretagogue |
08/12/1998 | EP0857018A1 Betulinic acid derivatives and uses therefor |
08/12/1998 | EP0825848A4 Novel collagen formulations |
08/12/1998 | EP0783528B1 Method of producing starch decomposition products |
08/12/1998 | EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
08/12/1998 | EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs |
08/12/1998 | EP0701450B1 Recombinant viruses and their use in gene therapy |
08/12/1998 | EP0696275B1 Vitamin d amide derivatives |
08/12/1998 | EP0689538B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
08/12/1998 | EP0686143B1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
08/12/1998 | EP0650474B1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
08/12/1998 | EP0646009B1 Use of guanosine in the manufacture of drugs for the treatment of brain dysfunction |
08/12/1998 | EP0631472B1 Antiviral condoms |
08/12/1998 | EP0629211B1 4-oxo-2-thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
08/12/1998 | EP0625903B1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
08/12/1998 | EP0596891B1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
08/12/1998 | EP0566709B1 Composition comprising a tramadol compound and acetaminophen, and its use |
08/12/1998 | EP0467991B1 Platelet membrane microparticles |
08/12/1998 | CN1190405A Triterpene derivatives and remely for liver diseases |
08/12/1998 | CN1190404A Neuroactive steroids of androstane and pregnane series |
08/12/1998 | CN1190401A C-4' modified adenosine kinase inhibitor |
08/12/1998 | CN1190396A Thiazoline derivative |
08/12/1998 | CN1190395A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-£(aminoiminomethyl) phenylalkyl|-azaheterocyclylamide compounds |
08/12/1998 | CN1190394A Bicyclic-aromatic compound |
08/12/1998 | CN1190393A Diaryldiamine derivatives and their use as delta opioid (ANT)-agonists |
08/12/1998 | CN1190391A Tricyclic benzazepine vasopressin antagonists |
08/12/1998 | CN1190390A Nitric oxide synthase inhibitors derived from cyclic amidines |
08/12/1998 | CN1190389A Farnesyl transferase inhibitors, its preparation and medicine composition thereof |
08/12/1998 | CN1190388A Semicarbazones having CNS activity and pharmaceutical preparations containing same |
08/12/1998 | CN1190351A Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with estrogen |
08/12/1998 | CN1190346A Pharmaceutical composition comprising lactobacillus plantarum and arginine |
08/12/1998 | CN1190345A Use of 1,4-dihydropyridine derivative in prevention and therapy of atherosclerotic degradation of arterial walls |
08/12/1998 | CN1190344A Use of 1, 2, 4-triazole derivative for manufacture of medicament for treatment of cancer |
08/12/1998 | CN1190097A Propiophenone derivatives and process for preparing the same |
08/12/1998 | CN1190096A Compounds analogous to thalidomide from class comprising piperidine-2,6-diones |
08/12/1998 | CN1190095A New chromone derivative with activity of restraining 5-fatty oxygenase |
08/12/1998 | CN1190016A Compound cold-preventing nose drops and their preparation |
08/12/1998 | CN1190002A Vermifuge composition for farm animal |
08/12/1998 | CN1039491C Tetrahydro-carbazole compound and its preparation and application |
08/11/1998 | US5792882 5-lipoxygenase inhibitors, antiallergens, antiinflammatory agents |
08/11/1998 | US5792874 Process for the manufacture of 8-chloro-6-(2-flourophenyl)-1-methyl-4H-imidazo 1,5A! 1,4!benzodiazepine (midazolam) |
08/11/1998 | US5792870 2-amino-3-aroyl-benzo β!thiophenes and methods for preparing and using same to produce 6-hdyroxy-2-(4-hydroxyphenyl)-3- 4-(2-aminoethoxy)-benzoyl!benzo β!thiophenes |
08/11/1998 | US5792858 Lysosphingolipid derivatives |
08/11/1998 | US5792847 2' Modified Oligonucleotides |
08/11/1998 | US5792842 Ganglioside GM3 derivative having fluorine atom at 9-position of sialic acid and intermediates therefor |
08/11/1998 | US5792840 Lipid A analogs having immunoactivating and anti-tumor activity |
08/11/1998 | US5792834 Polyethylene-protein conjugates |
08/11/1998 | US5792799 Parkinson's disease; side effect reduction using a nonheterocyclic inhibitor of an amine or hydrazine, e.g chlorgyline; inhibits in the brain not the intestines |
08/11/1998 | US5792798 Method for inhibiting plasminogen activator inhibitor 1 |
08/11/1998 | US5792797 Pharmaceutical compounds |
08/11/1998 | US5792796 Administering gabapentin, derivatives and salts |
08/11/1998 | US5792795 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
08/11/1998 | US5792794 Retinoylamide based derivatives of sphingoid bases |
08/11/1998 | US5792790 Method for improving weight gain and feed utilization in livestock |
08/11/1998 | US5792789 Acids and esters of diosmetin |
08/11/1998 | US5792788 Substituted thiophenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
08/11/1998 | US5792787 Suppression of the expression of vcam-1, vascular cellular adhesion molicule, by administering a n-hetero dithiodicarbamates, e.g., sodium pyrrolidine n-dithiocarbamate |
08/11/1998 | US5792786 Sustained and prolonged wound healing agents |